Loading…
General medicine - private practice in საბურთალოს რაიონი, ქ. თბილისი. Address: საქართველო, თბილისი, საბურთალოს რაიონი, ვაჟა-ფშაველას გამზ., N 35, ბ N 42.
GCAP internal — Sectors and enrichment.xlsx (2026-06-10)
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 85.3% | 87.8% | 30.3% | 91.1% | 81.6% | 92.2% |
| EBITDA Margin | 28.9% | 15.6% | -38.5% | 6.8% | -5.8% | 14.2% |
| EBITDAR | 146 | 68 | -168 | 38 | -23 | 74 |
| EBITDAR Margin | 29.6% | 16.4% | -37.4% | 7.5% | -5.0% | 14.9% |
| EBIT Margin | 28.9% | 15.6% | -38.5% | -12.6% | -17.6% | 2.6% |
| Net Profit Margin | 22.6% | 5.2% | -41.8% | -19.9% | -26.3% | -10.8% |
| Operating Expense % of Sales | 56.4% | 72.2% | 68.8% | 84.4% | 87.4% | 78.0% |
| Returns | ||||||
| Return on Assets (ROA) | 6.9% | 1.5% | -15.0% | -9.5% | -11.3% | -5.1% |
| Return on Equity (ROE) | 51.6% | 9.1% | -370.7% | N/A | N/A | -17.9% |
| ROIC [EBIT / Invested Capital] | 9.6% | 4.5% | -14.1% | -6.1% | -9.2% | 1.3% |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 81.9% | 83.7% | 96.0% | 104.2% | 98.3% | 71.6% |
| Debt-to-Equity | 6.08x | 5.15x | 23.73x | -21.76x | -6.10x | 2.52x |
| Debt-to-EBITDA | 9.22x | 18.91x | N/A | 32.23x | N/A | 10.74x |
| Equity-to-Assets | 13.5% | 16.3% | 4.0% | -4.8% | -16.1% | 28.4% |
| Net Debt | 1,274 | 1,201 | 1,178 | 1,100 | 1,043 | 703 |
| Cash & Equivalents | 39 | 25 | 22 | 18 | 3 | 49 |
| Total Debt | 1,314 | 1,225 | 1,200 | 1,118 | 1,046 | 752 |
| Liquidity & working capital | ||||||
| Current Ratio | 0.96x | N/A | N/A | 7.95x | 0.24x | N/A |
| Quick Ratio | 0.96x | N/A | N/A | 7.95x | 0.24x | N/A |
| Cash Ratio | 0.53x | N/A | N/A | 2.72x | 0.02x | N/A |
| Total Current Assets | 72 | 103 | 99 | 54 | 45 | 49 |
| Total Current Liabilities | 75 | N/A | N/A | 7 | 190 | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A |
| Trade Receivables | 32 | 79 | 77 | 35 | 41 | 38 |
| Trade Payables | 75 | N/A | N/A | N/A | N/A | N/A |
| Net Working Capital | -3 | 103 | 99 | 47 | -145 | 49 |
| Net Working Capital % of Revenue | -0.6% | 24.8% | 22.1% | 9.2% | -31.7% | 9.9% |
| Trade Working Capital | -42 | 79 | 77 | 35 | 41 | 38 |
| Trade Working Capital % of Revenue | -8.6% | 18.9% | 17.1% | 6.9% | 9.0% | 7.8% |
| Change in Trade Working Capital | N/A | 121 | -2 | -41 | 6 | -3 |
| Turnover & efficiency | ||||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover | 15.20x | 5.29x | 5.85x | 14.51x | 11.11x | 12.89x |
| Days Sales Outstanding (DSO) | 24.0 | 69.0 | 62.4 | 25.2 | 32.9 | 28.3 |
| Payables Turnover | 0.97x | N/A | N/A | N/A | N/A | N/A |
| Days Payable Outstanding (DPO) | 377.3 | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion Cycle | -353.3 days | 69.0 days | 62.4 days | 25.2 days | 32.9 days | 28.3 days |
| Asset Turnover | 0.31x | 0.28x | 0.36x | 0.48x | 0.43x | 0.47x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 20 | -15 | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | 20 | -15 | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | 14.1% | -22.8% | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →